Comparative responsiveness of the EQ-5D and SF-6D to improvement in patients with rheumatoid arthritis treated with TNF-blockers

Share/Save/Bookmark

Buitinga, Laurien and Braakman-Jansen, Louise M.A. and Taal, Erik and Kievit, Wietske and Visser, Henk and Riel van, Piet L.C.M. and Laar van de, Mart A.F.J. (2012) Comparative responsiveness of the EQ-5D and SF-6D to improvement in patients with rheumatoid arthritis treated with TNF-blockers. Arthritis care and research, 64 (6). 826 - 832. ISSN 0893-7524

[img]PDF
Restricted to UT campus only
: Request a copy
114Kb
Abstract:Objective


For cost-utility analyses of health technologies, utilities are commonly measured with the EuroQol-5D (EQ-5D) or the Short Form 6D (SF-6D). Although most studies in rheumatoid arthritis (RA) found the SF-6D to be more responsive than the EQ-5D, evidence is not convincing. The aim of this study was to compare the responsiveness of the EQ-5D and SF-6D to improvement in RA patients treated with tumor necrosis factor (TNF) blockers.


Methods


Data from 278 RA patients included in the Dutch Rheumatoid Arthritis Monitoring registry were used. Internal responsiveness over 1 year was evaluated by using standardized response means (SRMs). External responsiveness was evaluated by using receiver operating characteristic curves based on perceived health change (self-reported health transition item Short Form 36) and change in disease activity (European League Against Rheumatism response criteria based on the Disease Activity Score in 28 joints).


Results


The scores of the EQ-5D and SF-6D changed moderately over 1 year (SRMs 0.50 and 0.67, respectively). The SF-6D was significantly more responsive to treatment than the EQ-5D. The EQ-5D and SF-6D were moderately able to correctly classify patients according to health transition (areas under the curve [AUCs] 0.67 and 0.72, respectively) and change in disease activity (AUCs 0.71 and 0.65, respectively).


Conclusion


The EQ-5D and SF-6D were only moderately responsive to improvement in RA patients treated with TNF blockers. Overall, the SF-6D was more responsive than the EQ-5D.
Item Type:Article
Copyright:© 2012 by the American College of Rheumatology
Faculty:
Behavioural Sciences (BS)
Research Group:
Link to this item:http://purl.utwente.nl/publications/82279
Official URL:http://dx.doi.org/10.1002/acr.21619
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page

Metis ID: 289533